Atara Biotherapeutics Stock Probability of Future Stock Price Finishing Under 11.77

Atara Biotherapeutics' future price is the expected price of Atara Biotherapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Atara Biotherapeutics performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
  
Please specify Atara Biotherapeutics' target price for which you would like Atara Biotherapeutics odds to be computed.

Atara Biotherapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Atara Biotherapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Atara Biotherapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Atara Biotherapeutics is not yet fully synchronised with the market data
Atara Biotherapeutics is way too risky over 90 days horizon
Atara Biotherapeutics has some characteristics of a very speculative penny stock
Atara Biotherapeutics appears to be risky and price may revert if volatility continues
Atara Biotherapeutics has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 8.57 M. Net Loss for the year was (276.13 M) with profit before overhead, payroll, taxes, and interest of 63.57 M.
Atara Biotherapeutics currently holds about 331.31 M in cash with (192.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.51.
Atara Biotherapeutics has a poor financial position based on the latest SEC disclosures
Roughly 22.0% of the company shares are held by company insiders

Atara Biotherapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Atara Stock often depends not only on the future outlook of the current and potential Atara Biotherapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Atara Biotherapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding4.2 M
Cash And Short Term Investments51.7 M

Atara Biotherapeutics Technical Analysis

Atara Biotherapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Atara Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Atara Biotherapeutics. In general, you should focus on analyzing Atara Stock price patterns and their correlations with different microeconomic environments and drivers.

Atara Biotherapeutics Predictive Forecast Models

Atara Biotherapeutics' time-series forecasting models is one of many Atara Biotherapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Atara Biotherapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Atara Biotherapeutics

Checking the ongoing alerts about Atara Biotherapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Atara Biotherapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Atara Biotherapeutics is not yet fully synchronised with the market data
Atara Biotherapeutics is way too risky over 90 days horizon
Atara Biotherapeutics has some characteristics of a very speculative penny stock
Atara Biotherapeutics appears to be risky and price may revert if volatility continues
Atara Biotherapeutics has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 8.57 M. Net Loss for the year was (276.13 M) with profit before overhead, payroll, taxes, and interest of 63.57 M.
Atara Biotherapeutics currently holds about 331.31 M in cash with (192.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.51.
Atara Biotherapeutics has a poor financial position based on the latest SEC disclosures
Roughly 22.0% of the company shares are held by company insiders
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Tools for Atara Stock

When running Atara Biotherapeutics' price analysis, check to measure Atara Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atara Biotherapeutics is operating at the current time. Most of Atara Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Atara Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atara Biotherapeutics' price. Additionally, you may evaluate how the addition of Atara Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon